Cetrotide is used in minimal stimulation IVF to prevent premature ovulation, typically administered later in the cycle than in conventional protocols, often only needing a single dose.

In minimal stimulation IVF, Cetrotide is used less frequently and in smaller doses compared to conventional IVF, where it is often part of a daily regimen to control ovulation timing.

Cetrotide suppresses premature LH surges during IVF cycles, controlling follicular development and timing for oocyte retrieval, thus reducing the risk of multiple pregnancies.

Cetrotide usage in IVF helps in precisely timing ovulation by inhibiting early LH surges, managing follicle development and decreasing chances of multiple pregnancies.

Administering Cetrotide in ART prevents early LH peaks, ensuring controlled follicle growth and ovulation, which strategically lowers multiple pregnancy risks.

Cetrotide is typically used in IVF to prevent premature ovulation and is less common in IUI, as IUI does not usually require such controlled ovarian stimulation.

Cetrotide can be used with IUI to help time ovulation more precisely, potentially increasing the chances of successful fertilization and pregnancy.

Using Cetrotide in IUI protocols may enhance fertility by preventing premature LH surges, thus timing ovulation more accurately, but is less commonly needed than in IVF.

Cetrotide is not standard for IUI as it is for IVF, because IUI involves less intense ovarian stimulation, reducing the need for such stringent control of ovulation.

Cetrotide can be used in IVF for endometriosis patients. It might reduce the risk of premature ovulation, potentially improving implantation success and ovarian response.

Cetrotide generally is safe for use in endometriosis patients undertaking IVF, helping to control ovarian stimulation and improve outcomes by preventing premature ovulation.